<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05115032</url>
  </required_header>
  <id_info>
    <org_study_id>H21-03343</org_study_id>
    <nct_id>NCT05115032</nct_id>
  </id_info>
  <brief_title>Posturography-assisted Vestibular Retraining for Stable Unilateral Vestibular Deficit</brief_title>
  <official_title>Randomized Controlled Trial of Computerized Dynamic Posturography-assisted Vestibular Retraining Compared With At-home Vestibular Rehabilitation Exercises for Stable Unilateral Vestibular Deficit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eytan A. David</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      People that have difficulty with balance have a higher risk of falling and reduced quality of&#xD;
      life. Some individuals can learn to compensate using their vision, their sense of where their&#xD;
      limbs are in space, and balance organs that are still intact. Rehabilitation exercises, which&#xD;
      typically involve shaking and nodding of the head, are often prescribed for dizzy patients&#xD;
      but are not effective for everyone. Our study aims to determine if specific exercises&#xD;
      performed on footplate sensors with visual feedback is superior to traditional rehabilitation&#xD;
      exercises done at home for improving balance and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized controlled interventional trial; single crossover; single-centre, open label</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SOT composite score</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in composite score of sensory organization test (Scores from 0-100; higher scores indicate better function)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dizziness Handicap Inventory</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in Dizziness Handicap Inventory (DHI); 16-30 Points (mild handicap), 32-52 Points (moderate handicap), 54+ Points (severe handicap)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ABC Score</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in Activity-specific Balance Confidence (ABC) score; (Scores from 0-100; higher scores indicate better function)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FES-I score</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in Fall Efficacy Scale-International (FES-I); possible scores 16-64, higher score indicates greater impairment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOT condition scores</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in mean SOT scores for conditions 1 through 6; (Scores from 0-100; higher scores indicate better function)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LOS directional control</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Limits of Stability test mean value of directional control of limits of stability; (Scores from 0-100; higher scores indicate better function)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LOS excursion</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Limits of Stability test mean endpoint excursion value and maximum excursion point; (Scores from 0-100; higher scores indicate better function)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DHI component scores</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Emotional, physical, and functional components of the DHI score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOT vestibular contribution</measure>
    <time_frame>Through study completion, 12 rehabilitation sessions, an average of 7 weeks</time_frame>
    <description>Change in mean value of SOT condition 5/mean value of SOT conditions 1; measured as a ratio, higher scores indicate a greater vestibular contribution to balance deficit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Dizziness</condition>
  <condition>Equilibrium; Disorder, Labyrinth</condition>
  <condition>Inner Ear Injury</condition>
  <condition>Inner Ear Disease</condition>
  <arm_group>
    <arm_group_label>Vestibular retraining with dynamic posturography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback</description>
  </arm_group>
  <arm_group>
    <arm_group_label>At-home rehabilitation exercises</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily rehabilitation exercises involving nodding and shaking of the head</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vestibular retraining with dynamic posturography</intervention_name>
    <description>12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback</description>
    <arm_group_label>Vestibular retraining with dynamic posturography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>At-home rehabilitation exercises</intervention_name>
    <description>6 weeks of daily rehabilitation exercises involving nodding and shaking of the head</description>
    <arm_group_label>At-home rehabilitation exercises</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Dizziness handicap inventory score at time of enrolment over 30&#xD;
&#xD;
          -  Unilateral vestibular weakness confirmed one or more of:&#xD;
&#xD;
               -  Videonystagmography showing unilateral weakness to bithermal testing of greater&#xD;
                  than 25%&#xD;
&#xD;
               -  VEMP: IAD asymmetry of greater than 40% for both cVEMP and oVEMP&#xD;
&#xD;
               -  VEMP: absence of both ocular and cervical vemp responses in one ear in the&#xD;
                  context of normal and replicable other ear&#xD;
&#xD;
               -  Or unilateral vestibular weakness idiopathic, not yet diagnosed (NYD)&#xD;
&#xD;
          -  Persistent imbalance following diagnosis of resolved benign paroxysmal positional&#xD;
             vertigo (BPPV)&#xD;
&#xD;
          -  Symptomatic&#xD;
&#xD;
          -  Long-standing/persistent symptoms greater than six months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Orthopedic deficit (eg. lower body joint dysfunction or lower joint replacement)&#xD;
&#xD;
          -  Neurological deficit or proprioception deficit&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Poor vision or blindness&#xD;
&#xD;
          -  Fluctuating vestibular symptoms, or condition known to fluctuate eg. Meni√®re's&#xD;
             disease, perilymphatic fistula (PLF) or superior canal dehiscence (SDCS)&#xD;
&#xD;
          -  Active benign paroxysmal positional vertigo (BPPV)&#xD;
&#xD;
          -  Undergoing treatment which may affect balance or ability to stand&#xD;
&#xD;
          -  Cognitive impairment that prevents understanding and responding to instructions&#xD;
             required to complete the study&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eytan A David, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eytan A David, MD</last_name>
    <phone>604 988 0597</phone>
    <email>dr.david@shaw.ca</email>
  </overall_contact>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Eytan A. David</investigator_full_name>
    <investigator_title>MD, FRCSC, Clinical Instructor, Dept. of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ear Diseases</mesh_term>
    <mesh_term>Labyrinth Diseases</mesh_term>
    <mesh_term>Labyrinthitis</mesh_term>
    <mesh_term>Dizziness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

